Google
ARMP — ARMATA PHARMACEUTICALS INC (Healthcare >> Biotechnology)
ARMP FAQ
What is ARMP's ROE?
ARMATA PHARMACEUTICALS INC reports a Return on Equity (ROE) of 90.70%.
What is ARMP's dividend yield?
ARMATA PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is ARMP's Deepscope Quality Score?
Deepscope rates ARMP's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ARMP?
Deepscope's AI Timing Score for ARMP is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ARMP belong to?
ARMATA PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 7.50
Price
-0.19
(-2.47%)
Day Change
|
|
|---|
ARMP, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 84 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 7.50 |
| PBV / Sector |
-0.91 / 4.63
|
| Earning Per Share | -7.51 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.53 M
GREAT
|
| Average 1W Daily Value |
0.34 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:13 |
| Symbol | ARMP |
| Name | ARMATA PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 36.71 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 282.31 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 5005 McConnell Avenue, Los Angeles, CA, United States, 90066
Phone: 310 665 2928
Website: https://www.armatapharma.com
Employees: 61
Sector: Healthcare >> Biotechnology
Description: Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
